Cite

HARVARD Citation

    Oliveira, L. et al. (2022). Cost-effectiveness analysis of Oncotype DX from a Brazilian private medicine perspective: a GBECAM multicenter retrospective study. Therapeutic advances in medical oncology. p. . [Online]. 
  
Back to record